Baker Bros. Advisors as of June 30, 2014
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 106 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Synageva Biopharma | 13.7 | $1.1B | 11M | 104.80 | |
Pharmacyclics | 10.5 | $861M | 9.6M | 89.71 | |
Seattle Genetics | 10.5 | $860M | 23M | 38.25 | |
Incyte Corporation (INCY) | 10.3 | $838M | 15M | 56.44 | |
Salix Pharmaceuticals Inc note 2.750% 5/1 | 7.2 | $586M | 219M | 2.67 | |
ACADIA Pharmaceuticals (ACAD) | 5.7 | $463M | 21M | 22.59 | |
Genomic Health | 4.6 | $374M | 14M | 27.40 | |
Incyte Corp Ltd conv | 4.5 | $371M | 275M | 1.35 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 4.2 | $347M | 259M | 1.34 | |
Incyte Corp note 4.750%10/0 | 3.2 | $259M | 40M | 6.41 | |
InterMune | 2.5 | $209M | 4.7M | 44.15 | |
Itmn 2 1/2 12/15/17 | 1.7 | $141M | 41M | 3.44 | |
BioCryst Pharmaceuticals (BCRX) | 1.7 | $139M | 11M | 12.75 | |
BioMarin Pharmaceutical (BMRN) | 1.4 | $119M | 1.9M | 62.21 | |
XOMA CORP Common equity shares | 1.3 | $106M | 23M | 4.59 | |
AVANIR Pharmaceuticals | 1.3 | $105M | 19M | 5.64 | |
Gilead Sciences conv | 1.0 | $78M | 22M | 3.64 | |
Vanda Pharmaceuticals (VNDA) | 0.9 | $71M | 4.4M | 16.18 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 0.9 | $71M | 23M | 3.08 | |
Anacor Pharmaceuticals In | 0.7 | $58M | 3.2M | 17.73 | |
Medivation Inc note 2.625% 4/0 | 0.7 | $55M | 35M | 1.59 | |
Dyax | 0.7 | $55M | 5.7M | 9.60 | |
Repros Therapeutics | 0.6 | $48M | 2.8M | 17.30 | |
Mirati Therapeutics | 0.6 | $48M | 2.4M | 20.00 | |
Questcor Pharmaceuticals | 0.6 | $46M | 500k | 92.49 | |
Cerus Corporation (CERS) | 0.5 | $43M | 10M | 4.15 | |
Derma Sciences | 0.5 | $41M | 3.5M | 11.56 | |
Intermune cv 5.0% | 0.5 | $40M | 17M | 2.36 | |
Versartis | 0.4 | $35M | 1.2M | 28.04 | |
Clovis Oncology | 0.4 | $33M | 793k | 41.41 | |
Heron Therapeutics (HRTX) | 0.4 | $32M | 2.6M | 12.32 | |
Acorda Therapeutics | 0.4 | $31M | 906k | 33.71 | |
Slxp 1 1/2 03/15/19 | 0.4 | $29M | 15M | 1.96 | |
Halozyme Therapeutics (HALO) | 0.3 | $27M | 2.8M | 9.88 | |
Gilead Sciences (GILD) | 0.3 | $21M | 256k | 82.91 | |
Arrowhead Research | 0.2 | $21M | 1.4M | 14.31 | |
Tg Therapeutics (TGTX) | 0.2 | $20M | 2.2M | 9.39 | |
XenoPort | 0.2 | $20M | 4.0M | 4.83 | |
Progenics Pharmaceuticals | 0.2 | $19M | 4.4M | 4.31 | |
Salix Pharmaceuticals Ltd cmn | 0.2 | $15M | 125k | 123.35 | |
Aegerion Pharmaceuticals | 0.2 | $13M | 414k | 32.09 | |
Omeros Corporation (OMER) | 0.2 | $13M | 754k | 17.40 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.2 | $13M | 13M | 1.03 | |
Kythera Biopharmaceuticals I | 0.1 | $12M | 311k | 38.37 | |
Aquinox Pharmaceuticals | 0.1 | $11M | 1.2M | 9.37 | |
Qlt | 0.1 | $9.5M | 1.5M | 6.18 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $9.2M | 200k | 45.82 | |
Osiris Therapeutics | 0.1 | $8.0M | 511k | 15.62 | |
Sangamo Biosciences (SGMO) | 0.1 | $8.0M | 523k | 15.27 | |
Neurocrine Biosciences (NBIX) | 0.1 | $8.2M | 555k | 14.84 | |
Infinity Pharmaceuticals (INFIQ) | 0.1 | $8.0M | 624k | 12.74 | |
Threshold Pharmaceuticals | 0.1 | $7.2M | 1.8M | 3.96 | |
Synergy Pharmaceuticals | 0.1 | $7.2M | 1.8M | 4.07 | |
Bluebird Bio (BLUE) | 0.1 | $7.6M | 198k | 38.57 | |
Aerie Pharmaceuticals | 0.1 | $7.4M | 299k | 24.77 | |
Array BioPharma | 0.1 | $6.5M | 1.4M | 4.56 | |
Ironwood Pharmaceuticals (IRWD) | 0.1 | $6.8M | 446k | 15.33 | |
Discovery Laboratories | 0.1 | $6.5M | 3.7M | 1.78 | |
Tekmira Pharmaceuticals Corporation | 0.1 | $6.3M | 484k | 13.06 | |
Epizyme | 0.1 | $6.7M | 214k | 31.12 | |
Macrogenics (MGNX) | 0.1 | $6.8M | 312k | 21.73 | |
Xencor (XNCR) | 0.1 | $6.3M | 542k | 11.62 | |
Novavax | 0.1 | $5.7M | 1.2M | 4.62 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $5.6M | 2.2M | 2.53 | |
Insmed (INSM) | 0.1 | $6.1M | 304k | 19.98 | |
Cytrx | 0.1 | $5.6M | 1.4M | 4.18 | |
Idera Pharmaceuticals | 0.1 | $4.7M | 1.6M | 2.90 | |
BioDelivery Sciences International | 0.1 | $5.1M | 421k | 12.07 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $4.6M | 73k | 62.29 | |
Zogenix | 0.1 | $4.7M | 2.4M | 2.01 | |
D Stemline Therapeutics | 0.1 | $5.0M | 339k | 14.67 | |
Ambit Bioscience | 0.1 | $5.2M | 748k | 6.91 | |
Ignyta | 0.1 | $5.2M | 571k | 9.09 | |
Galectin Therapeutics (GALT) | 0.1 | $4.1M | 300k | 13.81 | |
Karyopharm Therapeutics (KPTI) | 0.1 | $4.4M | 94k | 46.55 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $4.5M | 100k | 44.89 | |
Concert Pharmaceuticals I equity | 0.1 | $4.0M | 399k | 10.10 | |
Celsus Therapeutics Plc sponsored adr ne | 0.1 | $3.7M | 674k | 5.50 | |
ISIS Pharmaceuticals | 0.0 | $3.3M | 96k | 34.45 | |
Achillion Pharmaceuticals | 0.0 | $3.3M | 438k | 7.57 | |
Biota Pharmaceuticals | 0.0 | $3.2M | 1.1M | 2.85 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $3.2M | 75k | 43.07 | |
Alder Biopharmaceuticals | 0.0 | $3.1M | 153k | 20.07 | |
Lipocine | 0.0 | $3.1M | 500k | 6.10 | |
Synta Pharmaceuticals | 0.0 | $2.0M | 500k | 4.09 | |
Foundation Medicine | 0.0 | $2.1M | 78k | 26.96 | |
Regado Biosciences | 0.0 | $2.7M | 400k | 6.79 | |
Mediwound Ltd cmn | 0.0 | $2.6M | 225k | 11.38 | |
Geron Corporation (GERN) | 0.0 | $1.3M | 403k | 3.21 | |
Rigel Pharmaceuticals (RIGL) | 0.0 | $1.7M | 482k | 3.63 | |
OraSure Technologies (OSUR) | 0.0 | $2.0M | 235k | 8.61 | |
Amicus Therapeutics (FOLD) | 0.0 | $1.6M | 482k | 3.34 | |
Ophthotech | 0.0 | $1.6M | 37k | 42.31 | |
La Jolla Pharmaceuticl Com Par | 0.0 | $2.0M | 222k | 9.18 | |
Achaogen | 0.0 | $1.4M | 100k | 13.96 | |
Mast Therapeutics | 0.0 | $1.9M | 3.0M | 0.63 | |
Salix Pharmaceuticals | 0.0 | $1.1M | 8.6k | 123.30 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $733k | 12k | 63.19 | |
ZIOPHARM Oncology | 0.0 | $986k | 245k | 4.03 | |
Tesaro | 0.0 | $971k | 31k | 31.10 | |
Receptos | 0.0 | $1.0M | 24k | 42.59 | |
Acceleron Pharma | 0.0 | $977k | 29k | 33.96 | |
Uniqure Nv (QURE) | 0.0 | $417k | 31k | 13.60 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $108k | 13k | 8.15 | |
Chemocentryx | 0.0 | $293k | 50k | 5.86 | |
Five Prime Therapeutics | 0.0 | $308k | 20k | 15.54 |